ATAC-Seq of Patient-Derived Xenografts in Metastatic Castration Resistant Prostate Cancer (LuCaP Series)
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 77 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Topic
- Prostate cancerThis series is part of our curated briefing on it.
- Samples
- 77 samples: 64 distinct titles, 10 of them repeatedGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE298042_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1267148 and SRA study SRP587344. Searching any of these in the dataset finder brings you back here.
How we read this: Read from 77 sample titles: 64 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9005582 105CR_rep1
- GSM9005583 105CR_rep2
- GSM9005584 105_rep1
- GSM9005585 136CR2_rep1
- GSM9005586 136CR_rep1
- GSM9005587 136_rep1
- GSM9005588 141_rep1
- GSM9005589 145_1_1X
- GSM9005590 145_1_2X
- GSM9005591 145.1_rep1
- GSM9005592 145.1_rep2
- GSM9005593 145.2_rep1
- GSM9005594 145_2
- GSM9005595 147CR_rep1
- GSM9005596 147_rep1
- GSM9005597 167CR_rep1
- GSM9005598 167_rep1
- GSM9005599 170.1_rep1
- GSM9005600 170.2_rep1
- GSM9005601 173.1_rep1
- GSM9005602 173.1_rep2
- GSM9005603 173.1_rep3
- GSM9005604 173_1_S6
- GSM9005605 173_1
- GSM9005606 174.1_rep1
- GSM9005607 176CR_rep1
- GSM9005608 176_rep1
- GSM9005609 189.3CR_rep1
- GSM9005610 189.3_rep1
- GSM9005611 189.4_rep1
- GSM9005612 208.1_rep1
- GSM9005613 208.2_rep1
- GSM9005614 208.4_rep1
- GSM9005615 23.1_rep1
- GSM9005616 23.1_rep2
- GSM9005617 23_1
- GSM9005618 235.2_rep1
- GSM9005619 235.3CR_rep1
- GSM9005620 235.3_rep1
- GSM9005621 243_rep1
+ 37 more — browse all 77 samples with per-sample file links →
- GSE115501 RNA sequencing on circulating tumor cells from prostate cancer patients 136 samples same disease briefing · shares prostate
- GSE222467 The RNA binding proteins LARP4A and LARP4B promote tumour growth and metastasis in prostate cancer and osteosarcoma 12 samples same disease briefing · shares prostate
- GSE300947 A novel six-biomarker panel identified from male breast cancer-associated fibroblasts demonstrates prognostic power for prostate tumors 6 samples same disease briefing · shares prostate
- GSE120181 Human prostate cancer cell line, 22Rv1: Control vs. luteolin treatment 2 samples same disease briefing · shares prostate
- GSE71008 Plasma extracellular RNA profiles in healthy and cancer patients 192 samples same disease briefing
- GSE242541 ONECUT2 is a druggable driver of luminal to basal breast cancer plasticity 12 samples same disease briefing
- GSE229394 Molecular and immune profiles linked to androgen response categories in metastatic castration-resistant prostate cancers (mCRPC) 56 samples shares metastatic, castration, resistant, prostate
- GSE252902 Increased chromatin accessibility drives transition to androgen receptor splice variant dependence in castration-resistant prostate cancer 130 samples shares castration, resistant, prostate
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.